Trinity Biotech | TRIB - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
Abbott USD 2.39B 27M 2026-03
Bayer EUR 321M 2.67B 2026-06
Bio-Rad Laboratories USD 542.1M 1.23B 2026-06
EDAP TMS EUR -8.94M 4.03M 2026-03
J&J USD 8.66B 839M 2026-06
Mesa Laboratories USD -2.22M 6.03M 2024-12
OraSure Technologies USD -18.43M 5.14M 2025-12
Plus Therapeutics USD -5.71M 1.29M 2025-12
Roche Holding CHF 11.17B 6.38B 2026-06
Siemens EUR 2.86B 89M 2026-03
Thermo Fisher Scientific USD 1.73B 389M 2026-03
Tosoh JPY 33.18B 3.4B 2026-06
Trinity Biotech USD -5.06M 10.74M 2025-09
Veracyte USD 26.52M 3.45M 2026-06